APRIL 2023LIFE SCIENCES REVIEW5CXO INSIGHTSCXO INSIGHTSTOP 10SOLUTIONS PROVIDERS IN EUROPE - 2023CancerImmunotherapyFEATURED COMPANY26The Value of Technology in PharmacovigilanceJames Curtis,Director,Software Development Engineering,UBC24Challenges to Clinical System in ChinaCheryl Chen,Director of Clinical Operations,BeiGene20Immunotherapy in lung cancer: building towards a patient-tailored futureJames Holland, PhD,Associate Scientific Director, and Kindiya Geghman, PhD,Vice President,Medical & Scientific Services, Ashfield MedComms, An Inizio Company T-CURXDr. Ulf Grawunder, CEO1814Expanding the Promise of Immunotherapy Beyond the Oncology RealmJames Riddle, MCSE, CIP, CPIA, CRQM, Vice President,Research Services & Strategic Consulting, Advarra28Leveraging Technology to Boost ImmunotherapyLi Chen,Vice President & General Manager, Biologics, West Pharmaceutical Services22Transforming Pharmacovigilance Using Technology ­ Help or Hype?Dr. Sebastian Horn,Vice President,Head of Global Patient Safety & Pharmacovigilance, Teva Pharmaceuticals
< Page 4 | Page 6 >